The FDA-cleared platform delivering ultra-portable 'Virtual AngioGram' technology through advanced real-time AI waveform analysis. Empowering clinicians with objective cardiac data anywhere, within 90 seconds.
PRECISION CARDIAC DIAGNOSTICS REIMAGINED
Pattern Recognition
CardioSpec AI leverages sophisticated machine learning algorithms to identify subtle anomalies within ECG and FCG waveforms. By isolating specific frequency bands and time-domain patterns, our platform delivers objective diagnostic clinical intelligence with unprecedented precision.
The platform's real-time analysis capabilities transform standard waveforms into actionable physiological indices. This automated oversight reduces diagnostic latency, allowing clinical teams to prioritize high-risk patients during the critical window of intervention.
Non-Invasive Precision:
Mapping the Invisible
The Power of
AI-Digital Angiography
Pinpoint Localization:
The CardioSpec AI platform moves beyond simple detection into localized cardiac intelligence. By utilizing proprietary AI spatial-mapping, we provide a non-invasive window into the heart’s vascular health:
-
Our algorithms analyze multi-vector electrical signals to identify the exact anatomical location of suspected coronary obstructions.
Quantified Severity
-
We don't just find the blockage; we assess the degree of stenosis (blockage percentage) by analyzing the specific morphological degradation of the heartbeat.
-
Achieve the diagnostic clarity of a traditional catheterization or a high-radiation CT scan through a simple, radiation-free, point-of-care session.
Zero-Invasive Risk
"We turn a standard 12 lead-set into a high-definition GPS for the heart. No needles, no radiation—just absolute clinical resonance."
DR. Ramesh Adiraju, MD, FACC
Founder & Medical Director, RENU-CA Research Institute
VIRTUAL ANGIOGRAM
TECHNICAL SPECIFICATIONS
- Standard 12-lead EKG interface
- Real-time Waveform Pattern Recognition
- Objective Indices for Rapid Diagnosis
- FDA-Cleared Signal Analysis Platform
- Ultra-Portable Clinical Form Factor
- Advanced ECG/FCG Diagnostic Indices
CLINICAL EXCELLENCE
The Standard of Precision Diagnosis
Proprietary Neural Signal Analysis
While a standard EKG merely records electrical activity, our AI performs a deep-wave audit of every heartbeat. It identifies sub-clinical micro-arrhythmias and "ischemic noise" that are invisible to traditional diagnostic software.
Structural-Functional Intelligence
The AI translates static structural data, such as a high Calcium Score, into a live functional risk assessment. It determines exactly how physical plaque burden is impacting the heart’s electrical stability in real-time.
Predictive Risk Stratification
CardioSpecAI eliminates diagnostic uncertainty by converting complex electrophysiological data into a clear, actionable risk score. This ensures "clinically invisible" or overlooked patients are immediately identified for life-saving intervention.
Ready to Transform Your Diagnostic Accuracy?
2018
Initial FDA 510(k) Clearance for AI-driven ECG pattern recognition and real-time analysis.
2020
Platform expansion: Automated waveform analysis for ultra-portable diagnostic tools.
2023
Validation of Virtual AngioGram technology for rapid clinical decision support indices.
2026
Partnership with NovaQuis Health creating the latest next-generation platform clearance for advanced real-time FCG waveform AI.
In partnership with:
© 2026 CS Marketing LLC - FDA-Cleared Diagnostic Platform. All Rights Reserved.